Cargando…
Comparative Proteome Identifies Complement Component 3-Mediated Immune Response as Key Difference of Colon Adenocarcinoma and Rectal Adenocarcinoma
Colorectal cancer (CRC) is one of the most lethal diseases with high morbidity and mortality worldwide. Clinically, tumors located in colon and rectum have diverse prognosis and therapeutic outcome. Here, we performed data mining derived from 20 CRC patient samples to compare proteomic difference be...
Autores principales: | Liang, Jun-Ze, Liang, Xiao-Ling, Zhong, Li-Ye, Wu, Chu-Tian, Zhang, Jing, Wang, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959172/ https://www.ncbi.nlm.nih.gov/pubmed/33732636 http://dx.doi.org/10.3389/fonc.2020.617890 |
Ejemplares similares
-
Proteomic Analysis of Protein Ubiquitination Events in Human Primary and Metastatic Colon Adenocarcinoma Tissues
por: Zhang, Yi, et al.
Publicado: (2020) -
Clinicopathological Characteristics and Mutation Spectrum of Colorectal Adenocarcinoma With Mucinous Component in a Chinese Cohort: Comparison With Classical Adenocarcinoma
por: Chen, Jingci, et al.
Publicado: (2020) -
Synchronous Adenocarcinoma of the Colon and Rectal Carcinoid
por: Vootla, Vamshidhar, et al.
Publicado: (2016) -
Hyperdense Pancreatic Ductal Adenocarcinoma: Clinical Characteristics and Proteomic Landscape
por: Xu, He, et al.
Publicado: (2021) -
Plasma Lipidomic Signature of Rectal Adenocarcinoma Reveals Potential Biomarkers
por: Fernandes Messias, Márcia Cristina, et al.
Publicado: (2018)